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Abstract
Nuclear genes encode most mitochondrial proteins, and their mutations cause diverse and debilitating clinical disorders. To
date, 1,200 of these mitochondrial genes have been recorded, while no standardized catalog exists of the associated clinical
phenotypes. Such a catalog would be useful to develop methods to analyze human phenotypic data, to determine genotype-
phenotype relations among many genes and diseases, and to support the clinical diagnosis of mitochondrial disorders. Here
we establish a clinical phenotype catalog of 174 mitochondrial disease genes and study associations of diseases and genes.
Phenotypic features such as clinical signs and symptoms were manually annotated from full-text medical articles and classified
based on the hierarchical MeSH ontology. This classification of phenotypic features of each gene allowed for the comparison
of diseases between different genes. In turn, we were then able to measure the phenotypic associations of disease genes for
which we calculated a quantitative value that is based on their shared phenotypic features. The results showed that genes
sharing more similar phenotypes have a stronger tendency for functional interactions, proving the usefulness of phenotype
similarity values in disease gene network analysis. We then constructed a functional network of mitochondrial genes and
discovered a higher connectivity for non-disease than for disease genes,and a tendency of disease genes to interact with each
other. Utilizing these differences, we propose 168 candidate genes that resemble the characteristic interaction patterns of
mitochondrial diseasegenes.Through theirnetworkassociations,thecandidatesarefurtherprioritizedforthe studyofspecific
disorders such as optic neuropathies and Parkinson disease. Most mitochondrial disease phenotypes involve several clinical
categories including neurologic, metabolic, and gastrointestinal disorders, which might indicate the effects of gene defects
within the mitochondrial system. The accompanying knowledgebase (http://www.mitophenome.org/) supports the study of
clinical diseases and associated genes.
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Introduction
Mitochondrial diseases are caused by an abnormal function of
mitochondria. They may be the result of spontaneous or inherited
mutations in the mitochondrial genome (mtDNA) or in nuclear
genes that code for mitochondrial components, but may also be
acquired secondary to adverse effects of drugs, infections, or other
environmental causes [1–3]. The mtDNA encodes only 13
proteins of the respiratory chain [4], while most of the estimated
1,500 mitochondrial proteins are nuclear-encoded [5]. Mitochon-
drial deficiencies often affect multiple tissues leading to multi-
system diseases that present with many phenotypic features. These
dysfunctions appear to be more prevalent in hereditary diseases
than previously anticipated [6–8] and have also been attributed to
the pathogenesis of common conditions associated with aging [3,9]
including neurodegenerative diseases [10], cardiovascular disor-
ders [11], diabetes mellitus [12], and several cancer types [13,14].
Medical case reports of specific gene defects have been crucial
to our understanding of clinical phenotypes. The list of
mitochondrial disease genes and case reports has grown rapidly,
while methods for defining and assaying clinical phenotypes are
still inadequate [15–17]. Accordingly, the accurate and systematic
comparison of clinical phenotypes associated with different disease
genes remains a major challenge. One limitation is the non-
standardized formats of such phenotypic data in the medical
literature and databases, which is difficult to overcome using
automated text mining [18,19]. An example are optic nerve
diseases for which multiple terms are found such as cranial nerve
II diseases, neural-optic lesion, optic disk disorder, and optic
atrophy. Higher-level phenome knowledgebases recently emerged
in an attempt to comprehensively index human phenotype data
[20–22]. The process of transforming descriptions of medical
diagnoses and procedures into universal computer-readable
medical code numbers involves manual reviews and annotations
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catalogs of clinical phenotypes are set within the context of the
existing literature, but are also limited by the inherent problems of
working with an evolving literature.
In this study, we catalogued detailed information on clinical
disease phenotypes of known mitochondrial gene defects that were
stored in a phenome knowledgebase. We then developed methods
to analyze the clinical phenotype information, to determine
associations of genes and diseases, and to compare different disease
genes based on their associated phenotypes. This approach was
used to predict disease gene similarities, which showed positive
correlations to their functional interactions. Our analysis of a
functional interaction network of mitochondrial genes revealed
distinct properties for disease and non-disease genes, which we
utilized to predict new disease candidate genes. Our knowledge-
base (www.mitophenome.org) represents a new resource for
studying links between disorders and genes. This can be integrated
with a variety of systems approaches [25] with the goal of
identifying disease gene variants in the individuals that carry them.
Results
Annotation of mitochondrial genes and diseases
We identified 174 nuclear-encoded mitochondrial genes (Table
S1) associated with 191 diseases in the Online Mendelian
Inheritance in Man (OMIM) database [26]. In order to
characterize these disorders in detail, we manually searched the
PubMed literature for their phenotypic features such as clinical
signs and symptoms, biochemical and clinical laboratory tests, and
neurological imaging findings. Our annotations consisted of three
steps that included the collection, definition, and classification of
phenotypic features for each disease gene. Importantly, we
individually matched the phenotypic features with standardized
descriptors in the Medical Subject Headings (MeSH) database
[27]. Within the hierarchical MeSH ontology, we localized the
individual feature position and then identified, for each feature,
the directly related parent descriptor or hypernym feature. Using
this approach, we reviewed 1,636 full-text articles reporting defects
or deficiencies in the 174 disease genes and individually extracted
phenotypic features for each gene. We then matched features with
MeSH descriptors and identified their hypernyms, which gener-
ated 502 features hierarchically classified within the mitochondrial
phenotype ontology (Table S2). At its root, the ontology has
fourteen features corresponding to fourteen major clinical
categories (CC) such as cardiovascular diseases or neurological
diseases. These CC are used to discriminate the more specific
features in each group: for example arrhythmia in the cardiovas-
cular CC and seizures in the neurologic CC. A subset of the
features in our phenotype ontology is listed in Table 1.
Clinical categories (CC) of mitochondrial disorders
A categorical breakdown of the 502 features in their fourteen
CC is shown in the inner circle of Figure 1A. While most CC
were comprised of more than twenty individual features, the
neurologic and metabolic CC contained the largest fraction of
features (18.5% and 14.3%, respectively). We then explored the
overall characteristics of mitochondrial phenotypes across all gene
defects. We had annotated a total of 9,407 gene-feature pairs
(Table S3) that included, for each of the 174 disease genes,
features identified through our literature search and hypernyms to
these features assigned through integration with the phenotype
ontology (see methods). A relative breakdown of the fourteen CC
across the 9,407 gene-feature pairs is shown in the outer circle of
Figure 1A. This analysis revealed CC patterns similar to the
categorical distribution above, with neurological (33.3%) and
metabolic (13.0%) features most prominently represented. To-
gether with the third largest CC of gastrointestinal (8.6%) diseases,
these three CC account for more than half of all features in all
gene-feature pairs studied. In comparison, the oncologic and
endocrinologic CC contained relative large numbers of features,
but these categories were associated with fewer genes and are less
frequently observed in mitochondrial disorders.
The distribution of phenotypes within CC is largely consistent
with the tissue distribution of energy expenditure in the resting
state, or basal metabolic rate (BMR), with brain contributing to
the highest proportion of the BMR (90% in newborns, 60% in
infants, and 25% in adults) [28], followed by liver (20–25% BMR)
and resting muscle (10–25% BMR). Mitochondria provide most of
the body’s energy [3], and measurements of mitochondrial
respiration have shown that brain tissue contains more active
respiratory chain complexes than liver, heart, or muscle [29].
Thus, our results showing a higher proportion of neurological,
metabolic, and gastrointestinal (e.g. liver diseases) features
positively correlate to BMR and respiratory-chain activities. A
related analysis of genes associated with the fourteen CC confirms
this observation (Figure 1B). While most genes were associated
with the neurologic, metabolic or gastrointestinal CC, these genes
also caused more features within these CC. For example, 154
genes were associated with the neurological CC with each gene
causing on average 20.3 neurological features. Although mito-
chondrial defects affect many cellular processes [5], the phenotype
patterns predominantly represent deficiencies in energy metabo-
lism with the nervous system being most susceptible. Like the gene-
expression patterns in the study of human phenotypic diversity
[30], CC patterns may aid to characterize and distinguish
phenotype groups such as mitochondrial disorders.
Clinical phenotype similarities between mitochondrial
disease genes
Inherited diseases often present with multiple phenotypic
features. The presence or absence of specific features is
Author Summary
An important prerequisite for successful disease gene
identification is the assessment, with minimal ambiguity,
of a particular clinical trait or phenotype. Even with years
of experience, recognizing and diagnosing mitochondrial
diseases is still a major hurdle in clinical medicine.
Computational tools supporting clinicians not only help
identify affected individuals, but also guide studies of the
genetic and biological causes of these disorders. In this
study we dissect and categorize individual clinical features,
signs, and symptoms of 174 disease genes and then
identify gene similarities based on their shared phenotypic
features. We demonstrate that genes sharing more similar
phenotypes have a stronger tendency for functional
interactions, proving the usefulness of phenotype similar-
ity values in disease gene network analysis. Our study of a
large functional network of mitochondrial genes revealed
distinct properties that differentiate disease and non-
disease genes. Disease genes showed a lower average
total connectivity but a tendency to interact with each
other; a finding that we used to predict 168 high-
probability disease candidates. The accompanying knowl-
edgebase allows for easy navigation between disease and
gene information. We believe the open source format will
support and encourage further research that will benefit
this and other human phenome projects.
Mitochondrial Disease Phenotypes
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1. Cardiovascular (110) 7. Immunologic (78) Neuromuscular-manifestations (129)
Arrhythmia (38) Autoimmune-diseases (2) Paralysis-Paresis (39)
Cardiomyopathy (44) Immune-deficiency (7) Reflexes-abnormal (78)
Cardiorespiratory-arrest (81) Infections (76) Hearing-disorders (30)
Hypertension (20) 8. Metabolic (143) Voice-disorders (11)
Hypotension (19) Acidosis (87) Stroke-like-episodes (10)
Myocardial-ischemia (6) Reye-like-symptoms (15) Developmental-delay (111)
2. Dermatologic (56) Dyslipidemias (14) Polyneuropathies (37)
Dermatitis (7) Diabetes-mellitus (18) Sleep-disorders (11)
Hair-diseases (15) Hyperglycemia (12) 11. Oncologic (29)
Pigmentation-disorders (11) Hyperinsulinism (5) Squamous-cell-neoplasms (4)
Hyperhidrosis (15) Hypoglycemia (52) Neuroendocrine-tumors (6)
Paleness (22) Hyperammonemia (40) Paraganglioma (3)
3. Endocrinologic (40) Hyperbilirubinemia (23) Leukemia-Lymphoma (9)
Adrenal-gland-diseases (14) Hemochromatosis (11) Breast-neoplasms (5)
Adrenal-insufficiency (9) Aminoacid-levels-abnormal (47) Colorectal-neoplasms (4)
Adrenocortical-hyperfunction (7) Water-electrolyte-imbalance (49) Hepatocellular-carcinoma (7)
Gonadal-disorders (23) Obesity (8) Leiomyoma (4)
Sex-differentiation-disorders (12) Fatty-acids-abnormal (21) Prostatic-neoplasms (4)
Parathyroid-diseases (5) Organic-acids-abnormal (69) Renal-cell-carcinoma (4)
Pituitary-diseases (10) Dicarboxylic-aciduria (20) 12. Ophthalmologic (87)
Thyroid-diseases (18) 9. Musculosceletal (95) Blepharoptosis (20)
4. Gastrointestinal (132) Osteoporosis (8) Cataract (15)
Cholestasis (16) Spinal-diseases (25) Pathologic-nystagmus (38)
Deglutition-disorders (29) Pathological-fractures (9) Ophthalmoplegia (15)
Gastroenteritis (28) Foot-deformities (20) Optic-nerve-diseases (34)
Intestinal-obstruction (13) Joint-diseases (18) Retinal-diseases (27)
Gastrointestinal-hemorrhage (9) Muscular-diseases (38) Color-vision-defects (7)
Liver-diseases (79) Rhabdomyolysis (8) 13. Psychiatric (51)
Fatty-liver (34) Microcephaly (39) Aggression (15)
Pancreatitis (9) 10. Neurologic (154) Feeding-behavior (8)
Abdominal-pain (31) Brain-diseases (135) Anxiety-disorders (18)
Feeding-difficulties (67) Intracranial-hemorrhages (17) Dementia (18)
Diarrhea (37) Seizures (97) Autistic-disorder (8)
Vomiting (80) Headache-disorders (21) Depressive-disorder (19)
5. Genitourinary (68) Leukoencephalopathy (39) Psychotic-disorders (20)
Infertility-male (7) Cerebellar-atrophy (28) Schizophrenia (8)
Hypospadias (6) Corpus-callosum-hypoplasia (18) 14. Respiratory (108)
Cystic-kidney-diseases (7) Choreatic-disorders (18) Hyperventilation (40)
Nephrocalcinosis (4) Dystonic-disorders (38) Respiratory-insufficiency (51)
Renal-insufficiency (30) Parkinsonian-disorders (12) Asthma (8)
Urination-disorders (12) Tremor (36) Pneumonia (40)
Menstruation-disturbances (9) Spinal-cord-diseases (29) Pulmonary-edema (14)
Pregnancy-complications (15) Neurogenic-bladder (10) Miscellaneous (151)
6. Hematologic (75) Ataxia (54) Fever (52)
Anemia (34) Speech-disorders (41) Hypothermia (17)
Blood-coagulation-disorders (24) Consciousness-disorders (65) Exercise-intolerance (36)
Petechiae (4) Memory-disorders (13) Failure-to-thrive (62)
Blood-platelet-disorders (21) Mental-retardation (68) Growth-deficiency (54)
Blood-protein-disorders (20) Hallucinations (14) Dysmorphisms-abnormalities (39)
Bone-marrow-diseases (20) Psychomotor-agitation (34) Odors (10)
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identify clinical traits [26]. It is hypothesized that phenotype
similarities of different disorders may indicate biological relation-
ships of the underlying genes [15,16]. Several systematic studies
have recently investigated genotype-phenotype associations in
human genetic disorders [19,31,32]. These approaches utilized
automated text mining to extract phenotype information, while
noting that currently available text formats and databases were not
designed as structured resources for human phenotype analysis
[19]. Another study utilized disorder terms from OMIM’s Morbid
map and manually annotated each disorder into one of 22
disorder classes [33], which are comparable to our CC. Notably,
the Morbid map terms represent only a small fraction of the
phenotype information of a clinical disorder and genes with
identical terms may cause phenotypic features from different CC.
In order to explore associations of genes and features in
mitochondrial diseases, we utilized our manually annotated
9,407 gene-feature pairs (Table S3). Evidence for each gene-
feature association is derived from one or more of 1,636 full-text
articles, where each article is linked to a PubMed unique identifier
(PMID). Using the PMID we computed the association ratio for
each gene-feature pair. This ratio represents the number of PMID
reporting a specific feature for a specific gene out of all PMID
annotated for this gene. In addition, we determined the association
ratios of pairs of genes linked to the same feature (see Methods).
The integration of association ratios for all features related to a
gene pair enabled the prediction of quantitative phenotypic
associations (QPA). Thus, QPA are a quantitative measure of
phenotype similarity of disease genes causing one or more identical
phenotypic feature.
Correlation of phenotypic associations and gene
functional interactions
We then compared disease genes with QPA and functional
interactions, in order to explore the hypothesis of phenotypic
similarities in functionally related genes [15,16]. We identified
1,928 gene pairs (n=139 genes) from a recent study with
Likelihood Ratios (LR) for gene functional interactions [34], and
for which we had predicted QPA (Table S4). Using rank
correlation, we detected positive associations with significant
confidence of QPA and LR for these disease gene pairs (Kendall:
p=4.67e-7; Spearman: p=3.72e-7). The results indicated that
genes with stronger evidence for functional interaction (higher LR)
displayed greater similarities in their associated disease phenotypes
(higher QPA). To select gene pairs with the highest correlation of
LR and QPA, we applied hierarchical clustering and identified
groups of gene pairs with higher to lower levels of association (see
Methods). In addition, we compared the 1,928 gene pairs with
both LR and QPA to pairs predicted by only one method.
Hypothesis testing revealed that these pairs showed on average
higher values for LR (p=6.86e-10) and QPA (p=0.029) than
pairs predicted by only one method (LR pairs only n=82; QPA
pairs only n=26,010). Thus, LR and QPA in combination could
be helpful in the analysis of disease gene associations.
In our next analysis we identified 39 disease genes encoding
components of seven mitochondrial protein complexes and two
metabolic pathways, representing nine functional modules (Table
S4). For each gene within a given module, we calculated the QPA
average relative to all other genes in the module (Figure 2A).
While genes within some modules were associated with similar
disease phenotypes (e.g. RCC1, RCC4), other modules appeared
phenotypically more diverse (e.g. BCKDH, TCA). We then
compared QPA of gene pairs within modules (n=262 pairs) to
pairs outside modules (n=27,676 pairs). This analysis revealed a
higher average phenotype similarity for gene pairs within versus
outside the nine modules (p=2.64e-5). We found a comparable
result in the analysis of gene functional interactions, with on
average higher LR for gene pairs within (n=182) versus pairs
outside these modules (n=1,828; p=1.86e-35). In summary, we
identified positive correlations of functional (LR) and phenotypic
(QPA) associations for many disease genes, with the most
prominent genotype-phenotype relationships in protein complexes
(Figure 2B). These results support findings of a recent study that
utilized automated text mining in OMIM to identify phenotypic
similarities within protein complexes [32]. However, it should be
noted that OMIM often combines genes into a single disease
record, if they encode subunits of the same protein complex (e.g.
BCKDH - Maple syrup urine disease, #248600; GCC - Glycine
encephalopathy, #605899). Potential circular reasoning in
correlating phenotypes and complexes could be reduced by
individual disease gene annotations. While statistically very
significant, the genotype-phenotype correlation values observed
in this and other studies are still rather small [35]. Possible
contributing factors are the imperfect information about gene-
gene and gene-disease associations and the environment.
Functional interactions of nuclear-encoded
mitochondrial genes
We then expanded our analysis and identified functional
interactions for 162 disease genes (DG) to 4,577 candidate genes
(CG) from a recent study [34]. As for the DG, we also extracted all
binary functional interactions for each CG in order to account for
all genome-wide interactions of all 4,739 genes studied (Table
S5). Of the CG, 531 genes had disease associations in OMIM [26]
and we consequently labeled those as DG. We recorded in total
more than 1.9 million gene interactions that included interactions
between disease genes (DG-DG), disease and candidate genes
(DG-CG, CG-DG), and candidate genes (CG-CG). We first
focused on the mitochondrial gene network and identified a set of
495 mitochondrial CG through data integration of two recent
studies [5,36]. These studies combined had predicted 1,200
human mitochondrial genes (Table S6). Our analysis of
functional interactions of all mitochondrial CG (495) and DG
(162) showed the following results: i. the total number of
Leukocyte-disorders (25) Irritability (39) RCC-deficiencies (42)
Lymphatic-diseases (8) Lethargy (69) Vitamin-responsive (24)
The 144 features are selected from a total of 502 features (Table S2) and are caused by defects in 174 nuclear-encoded mitochondrial genes. Every feature is associated
with the number of genes shown in parentheses. The hierarchical structure of features within the phenotype ontology was established using standardized MeSH
descriptors (not shown). The fourteen CC in bold serve as headers for features within them. Unassigned features are grouped under ‘Miscellaneous’.
doi:10.1371/journal.pcbi.1000374.t001
Table 1. cont.
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was higher for CG than for DG (p=7.93e-6); ii. the relative
number of DG interactions (i[disease-genes]/i[all-genes]), which
was recorded to all known human DG, was higher for DG than for
CG (p=6.37e-7); and iii. the relative number of interactions to
human orthologs of mouse (i[mouse-essential]/i[all-genes]) and
yeast (i[yeast-essential]/i[all-genes]) essential genes [33,37] was
higher for the DG than the CG (mouse p=1.72e-4; yeast
p=0.013). These results indicated that mitochondrial CG and DG
can be distinguished based on functional interaction patterns.
In a related analysis, we compared the functional interactions of
DG (493) and CG (3551) located outside the mitochondrial
organelle (Table 2), which showed similar results (i., ii. and iii.) as
for the mitochondrial gene groups (see Methods for data).
However, the comparison of mitochondrial and non-mitochon-
drial genes revealed some surprises. The total number of
interactions for non-mitochondrial DG was higher than for
mitochondrial DG (p=6.5e-29), and the number of interactions
for non-mitochondrial CG was higher than for mitochondrial CG
(p=2.37e-93). Notably, the non-mitochondrial DG had on
average more interactions than the mitochondrial CG
(p=1.87e-19). To further investigate these differences, we
literature-annotated detailed information on intracellular localiza-
tions of gene products (Table S1). Out of the 162 DG, 115 genes
had only evidence for mitochondrial localizations, while 47 DG
also localized to additional compartments (e.g. nucleus, cyto-
plasm). In addition, we identified 38 DG out of the 4,577 CG
(Table S6) with likely mitochondrial localizations [5,36]. These
38 DG (p=0.06) and the 47 DG with multiple localizations
(p=0.51) tended to have more interactions than the 115
mitochondria-only DG although both results were not statistically
significant. In summary, our analysis identified a higher average
connectivity for non-disease genes (CG) than for DG, which was
detected for both mitochondrial and non-mitochondrial genes,
and secondly, fewer functional interactions of mitochondrial than
for non-mitochondrial genes. These findings are supported by a
separate gene fraction analysis (Figure 3), where we studied the
number of interactions of genes in the different gene groups and
the distribution of these interactions over the whole network (see
Methods).
Candidate genes for mitochondrial disorders
In the last decade, several systematic studies have predicted
functional candidate genes in genomic linkage intervals of
mitochondrial diseases [38–42]. In principle, all genes from a
given interval are ‘‘benchmarked’’ against a database of annotated
proteins [5], and genes identical to or functionally similar to the
reference proteins are prioritized for mutational screens in affected
individuals. Here, we build on the success of these approaches and
predict new DG from a larger list of mitochondrial CG.
Considering the identified interaction differences of disease and
non-disease genes, we performed a supervised discriminant
analysis [43] of all 695 mitochondrial genes using the five
attributes of gene functional interactions (Table S5). Out of the
495 mitochondrial CG, 254 genes were predicted as DG with a
true positive rate of 80.2% based on the confirmed known DG. In
addition, 26 of the 38 DG with likely mitochondrial localization,
which we input-labeled as CG to serve as controls, were correctly
classified as DG. As an alternative tool, we ran a supervised
Bayesian network approach [44,45]. We first defined a training set
of 100 typical out of the 162 mitochondrial DG based on their
median of total gene interactions. Accordingly, 100 typical CG
were selected from the 495 mitochondrial CG. The network
analysis correctly identified 56.8% of the DG, 16 out of the 38
Figure 1. Distribution of clinical phenotypic features in
mitochondrial diseases. (A) The inner circle shows the distribution
of 502 phenotypic features among fourteen clinical categories (CC), plus
a ‘Miscellaneous’ category containing unassigned features. The
numbers show the fraction in % of all features in one CC compared
to all 502 features. The outer circle shows the distribution of features
related to CC within the 9,407 gene-feature pairs, with the frequency in
% of all features in one CC. (B) Number of genes with features in a
specific CC (y-axis) in correlation to the average number of CC-specific
features caused by these genes (x-axis). 154 genes caused neurological
features with an average of 20.2 neurological features per gene.
Phenotypically, most mitochondrial gene defects are related to
neurological, metabolic and gastrointestinal diseases.
doi:10.1371/journal.pcbi.1000374.g001
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PLoS Computational Biology | www.ploscompbiol.org 5 April 2009 | Volume 5 | Issue 4 | e1000374Figure 2. Phenotype similarity of genes related to mitochondrial protein complexes and pathways. (A) For each gene (black dots), the
average QPA (y-axis) to all other genes within a functional module was calculated. Red lines represent the median (50th percentile) of all QPA
averages within a module. Boxes indicate the 25th and 75th quartiles, with minimum and maximum data points as lines that extend from each end of
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CG. Overlapping the two approaches predicted 168 novel
mitochondrial DG with an estimated true positive rate of 85.8%
(139 out of 162 DG) based on the correctly classified DG (Table
S8). The newly predicted disease candidates can be prioritized
from the larger set of functional CG in linkage intervals of
mitochondrial disorders (Table 3).
Discussion
The creation of human phenomic databases has been suggested
to systematically collect and analyze phenotypic information
[15,20–22]. In this study, we established a clinical phenotype
catalog of 174 mitochondrial disease genes (Table 1) that account
for ,10% of all known disease genes [26]. In order to define and
classify clinical phenotypes from 1,636 medical case reports, we
developed a terminologic system that is based on the hierarchical
MeSH ontology. Because automated text mining is limited in
annotating clinical disorders from the literature [18,19], our
mapping of ‘‘phenotypes to language’’ required the manual review
of each full-text article [17]. This classification of phenotypic
features for each gene allowed the comparison of disorders
between different disease genes (Figure 1). To measure clinical
phenotype similarity between disease genes, we calculated a
numerical value (QPA, quantitative phenotypic associations) that
takes into account all annotated gene-feature associations, the
overlap of features between two disease genes, and the frequency
of the shared feature across all genes. Thus, QPA are based on the
hypothesis that the value of a feature varies inversely with the
number of genes with which it is associated [16].
The analysis of disease gene pairs with QPA in comparison to
Likelihood Ratios (LR) for functional interactions [34] showed
positive correlations. Disease genes with stronger evidence for
functional interactions (higher LR) displayed greater similarities in
their clinical phenotypes (higher QPA). We discovered the most
prominent phenotypic similarities within mitochondrial protein
complexes (Figure 2) supporting previously predicted genotype-
phenotype associations of protein complexes [32]. However, we also
noted complexes with lower phenotypic similarities (e.g. BCKDH -
Maple syrup urine disease; GCC - Glycine encephalopathy)
highlighting the importance for individual gene inspection. Since
this analysis was limited to disease genes (DG), we were interested in
learning the properties of a larger network that included non-disease
candidate genes (CG). Utilizing the genome-wide study by Franke et
al. [34], we created a functional network of more than 1.9 million
gene interactions for 162 mitochondrial DG and 4,577 CG. Our
analysis identified significant differences in functional interactions for
DG and CG with a higher average connectivity for CG. This
difference was detected for both the mitochondrial and non-
mitochondrial gene groups (Table 2). In addition, while the total
number of DG interactions was similar for DG and CG, the relative
fraction of DG interactions (i[disease-genes]/i[all-genes]) was higher
forDGindicatingthatDGaremorelikelytointeractwitheachother.
Previous smaller scale studies (,1006 fewer interactions) have
predicted intermediate and peripheral positions of DG in gene
functional networks with relatively fewer interactions than essential
genes [33,46]. Our results expand on this hypothesis showing that
essential and non-disease genes (CG) can be distinguished from DG
based on gene interaction patterns (Figure 3). Furthermore, we also
identified network properties differentiating mitochondrial from non-
the box. The grand mean of all modules (blue line) is the QPA average across all gene pairs of all nine modules, which was significantly higher than for
pairs outside modules (orange line). (B) Module gene relationships are predicted through functional (LR) and phenotypic (QPA) associations showing
the usefulness of phenotype similarity scores in disease gene network analysis. The edge colors are: Red – gene pairs with highest correlation of QPA
and LR; blue – gene pairs with lower QPA-LR correlation; orange and light blue – gene pairs with QPA only at higher (.=0.4) and lower confidence
(,0.4), respectively (see Table S4 for data). Diseases caused by the six genes labeled ‘‘*’’ are known to respond to vitamin treatments (riboflavin,
thiamine, and pyridoxine). Abbreviations: AKDH, Alpha ketoglutarate dehydrogenase; BCKDH, Branched chain alpha keto acid dehydrogenase; GCC,
Glycine cleavage system; PDH, Pyruvate dehydrogenase; RCC, Respiratory chain complex; TCA, Tricarboxylic acid cycle; UC, Urea cycle.
doi:10.1371/journal.pcbi.1000374.g002
Table 2. Molecular interactions of mitochondria and non-mitochondria genes.
Gene group (genes/group) i[all-genes] i[disease-genes] i[mouse-essential] i[yeast-essential] i[mito-genes]
DG mitochondria (162) 120.91 (62) 26.14 (17.5) 13.23 (6) 20.56 (8.5) 42.24 (22)
CG mitochondria (495) 190.19 (114) 23.93 (14) 14.75 (6) 36.51 (23) 49.81(37)
DG non-mitochondria (493) 396.71 (154) 48.29 (22) 75.01 (17) 29.86 (19) 16.91 (8)
CG non-mitochondria (3551) 459.74 (275) 48.81 (21) 78.4 (21) 44.48 (34) 21.38 (10)
DG mito-only local. (115) 114.48 (67) 27.23 (19) 10.68 (6) 20.14 (9) 48.07 (25)
DG mito+other local. (47) 136.66 (56) 23.47 (14) 19.47 (7) 21.57 (6) 27.98 (18)
DG mito-predict local. (38) 192 (107) 31.18 (18) 22.03 (9) 36.13 (15) 45.76 (30)
Mouse essential genes (597) 598.22 (480) 69.64 (52) 116.7 (63) 39.94 (30) 17.31 (8)
Yeast essential genes (609) 354.96 (230) 33.51 (18) 40.51 (16) 66.15 (54) 37.03 (25)
The total 4,739 genes studied are separated into nine gene groups with the number of disease genes (DG) and candidate genes (CG) in each group in parenthesis (see
Table S5 for individual gene data). DG products with intracellular localization to only mitochondria (115 genes) and mitochondria-and-other-localizations (47 genes)
are subsets of the 162 mitochondrial DG. The human orthologs to mouse and yeast essential genes are subsets of all 4,739 genes. The five data columns showt h e
average number of interactions (i) of each group to all genes in the human genome (all-genes); all known human disease genes (disease-genes); all human orthologs of
essential mouse genes (mouse-essential); all human orthologs of essential yeast genes; and to all nuclear-encoded human mitochondrial genes (mito-genes). The
numbers in parenthesis show the median number of interactions for each group and attribute, respectively. The findings indicated distinct properties in gene molecular
interactions for DG and CG, as well as for mitochondria and non-mitochondria genes.
doi:10.1371/journal.pcbi.1000374.t002
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connectivity, which may be due to the double-membrane structure of
the organelle limiting the detection of protein-protein interactions
[47]. However, the higher connectivity between mitochondrial genes
may relativize this problem. Future studies will help to answer the
question of the connectivity of mitochondrial genes and perhaps
genes of other cellular compartments as well.
In the final part of this study we utilized the discovered
interaction patterns to predict new mitochondrial DG. Using two
different approaches, we identified 168 non-disease genes that
resembled the characteristic interaction patterns of the 162
mitochondrial DG (estimated TP rate=85.8%). If diseases are
linked to a genomic interval, the predicted DG can be prioritized
from a larger list of functional candidates for mutational screen in
affected individuals (Table 3). For example, the optic atrophy 2
(OPA2) linkage interval contains seven mitochondrial genes that
include three known DG of which HSD17B10 is associated with
optic atrophy [48–50], and three predicted DG of which two genes
(NDUFB11, TIMM17B) interact with mitochondrial DG causing
optic atrophy. Our phenome knowledgebase (www.mitophenome.
org) can also be applied to investigate disorders through gene
network association, in particular common conditions that are
caused by single gene defects in a subset of patients [51]. For
example, a search for Parkinson disease returns 12 mitochondrial
DG with interactions to 24 predicted DG (e.g. CCS, MECR,
PRKAR2B). Similarly, seizures and mental retardation, a
common combination of mitochondrial features, is caused by 59
DG that interact with 124 predicted DG. With the decreasing cost
of DNA sequencing, high-throughput screens linking phenotypes
with genotypes will further increase the accuracy of gene-feature
associations. To this end, easy navigation between clinical
phenotype and gene information promises to aid in the recognition
and diagnosis of mitochondrial disorders.
Methods
Mitochondrial disease genes
We identified 174 disease genes that encode proteins targeted to
mitochondria (Table S1). While most gene defects are inherited
as Mendelian traits; ACSL6, BAX, BCL2, ME2, MTHFD1,
PARL, PHB, UCP1, and UCP2 are disease susceptibility alleles;
DLST, OGDH, and PCK2 are disease-associated protein
deficiencies; and HTRA2, MTCP1, SLC25A16, and WWOX
cause disorders of unknown inheritance patterns. Table S1 has
also the annotations and PMID references (col. I) for intracellular
protein localizations and the 39 genes encoding components of
nine mitochondrial protein complexes and pathways (col. J).
Additional mitochondrial genes (Table S6) were identified
through integration of two studies [5,36] that had combined
predicted 1,200 mitochondrial genes.
Phenotypic feature annotation
For each of the 174 disease genes, we identified individual studies
and case reports describing a gene defect or deficiency and associated
phenotype information. Manual extraction and annotation probably
results in more specific and comprehensive data, with far fewer false-
Figure 3. Functional interactions of human mitochondrial genes. For each gene group, we calculated the fraction of genes (y-axis) that
interact with k other genes (x-axis). The gene group fractions were calculated for interactions to all human genes (A), all disease genes (B), and all
mitochondrial genes (C). The color codes of the gene groups with their respective regression line slopes and p-values (in parenthesis) are shown in
the table (D), with all results including correlation coefficients listed in Table S7. The fraction analysis of all gene interactions (A) showed a higher
network connectivity for non-disease genes (CG) than for disease genes (DG), as indicated by the larger absolute value of the negative DG regression
slope. In contrast, the connectivity to disease genes is relatively higher for DG than for CG suggesting a tendency for DG to interact with each other
(B). Human orthologs to mouse essential genes had the highest network connectivity, while the mitochondrial gene groups had the highest
tendency to interact to other mitochondrial genes (C).
doi:10.1371/journal.pcbi.1000374.g003
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processing and high-throughput screening [23]. Annotation of 1,636
full-text articles identified 461 phenotypic features that included the
definition of specific clinical terms for each feature. Features were
definednarrowlyenoughsothatclinicaldiagnosesmappedtoasingle
feature. This process was essential as phenotype descriptions were not
consistent and often varied between different studies (see Table S3,
col. E). To define features, we utilized standardized descriptors in the
Medical Subject Headings (MeSH) database under the ‘‘Diseases’’
(coded under C), and the ‘‘Psychiatry and Psychology’’ (coded under
F) branches of the MeSH hierarchy used by the National Library of
Medicine (NLM). Individual matching of features with MeSH
descriptors revealed their positions in the hierarchical MeSH
ontology, together with the parent descriptor, the directly related
hypernym feature. For this analysis, we assigned each feature to only
one position in MeSH (e.g. diabetes mellitus has MeSH positions
C18.452.394.750 and C19.246; we chose the first category). We only
added hypernyms to the ontology that were directly related to at least
two features. Some features were added manually because they had
no clear match with MeSH descriptors. By integrating our 461
features with their 41 hypernyms, we identified 502 features that are
hierarchically classified within the mitochondrial phenotype ontology
(Table S2).
Gene-feature pair annotation
We used 1,636 full-text articles to manually annotate 6,361
gene-feature pairs, each of which was created from at least one
original PubMed article with a unique identifier (PMID). On
average, we identified 2.77 PMID per gene-feature pair, and 9.87
PMID per gene. Further, we assigned each gene-feature pair to a
unique OMIM disease record (e.g. 277900 for Wilson disease),
which described the disorder and was referenced in many articles.
We computationally integrated the 6,361 gene-feature pairs with
our phenotype ontology, resulting in 10,202 gene-feature pairs
(Table S3). This integration also assigned the PMID of each gene-
feature pair to its directly related hypernym gene-feature pair.
PMID assigned through ontology integration are labeled ‘‘#’’ (col.
G). Because gene-feature pairs may be associated with more than
one OMIM disease record, we consolidated the 10,202 gene-
feature pairs (and their PMID) into 9,407 unique pairs. For
example, the gene POLG is associated with ophthalmoplegia and
three OMIM disease records (157640, 258450, 607459).
Quantitative phenotypic associations (QPA)
The association ratio for each gene-feature pair is the fraction of
PMID reporting a specific feature for a specific gene out of the
total number of PMID annotated for that gene. The feature Fi
specific association ratio for gene pair A–B (rFi) was calculated as:
rFi~ PMID of gene A-feature Fi ðÞ =PMID for gene AÞ
 
PMID for gene B-feature Fi ðÞ = PMID for gene B ðÞ
We considered the important weight wi of feature Fi for gene pair
Table 3. Prioritizing candidate genes for mitochondrial disorders.
Mitochondrial Disorder OMIM Phenotypic features Linkage interval
Size
(Mb)
Gene
loci
Mitochondrial genes marked
(*) if known, and (
#)i f
predicted disease gene
Optic atrophy 2, OPA2 311050 optic nerve disease DXS993-DXS991 14.5 352 MAOA*, ALAS2*, HSD17B10*;
MAOB
#, NDUFB11
#,
TIMM17B
#; ARAF
Optic atrophy 4, OPA4 605293 optic nerve disease D18S34-D18S479 8.8 58 ATP5A1
#, ACAA2
#
Optic atrophy 5, OPA5 610708 optic nerve disease D22S1148-D22S283 10.4 189 HSCB
#, PISD
#, TXN2
#, UCRC
#,
TST
#; NIPSNAP1, MTP18
Optic atrophy 6, OPA6 258500 optic nerve disease D8S1702-D8S1794 12.3 86 UQCRB*, DECR1* PPM2C*;
SLC7A13
#; SLC7A13, FAM82B,
MTERFD1
Thyroid carcinoma,
nonmedullary, TCO
601992 thyroid neoplasms D19S884-D19S221 4.5 153 TIMM44
#, NDUFA7
#; MRPL4,
FDX1L, ECSIT
Paragangliomas 2, PGL2 601650 neuroendocrine tumors D11S956-PYGM 6.0 193 BAD
#, PRDX5
#, GLYAT
#,
C11orf79
#, COX8A
#; MRPL16,
GLYATL1, GLYATL2
Multiple mitochon-drial
dysfunction syndrome, MMDFS
605711 muscle weakness, seizures, lethargy,
feeding difficulties,
D2S1337-D2S441 8.8 79 MDH1
#; CCT4, ENSG00000119838
Cowchock syndrome; NADMR 310490 muscle weakness, mental retardation,
hearing disorder, polyneuropathy
DXS425-HPRT 13.7 152 NDUFA1*; AIFM1
#,G L U D 2
#,
SLC25A14
#
MEHMO syndrome 300148 mental retardation, seizures, obesity,
hypogonadism
DXS365-CYBB 15.9 139 GK*; ACOT9
#, PDK3
#; APOO
Gustavson syndrome, GUST 309555 mental retardation, optic nerve
disease, seizures, deafness
DXS458-DXS424 20.2 285 ACSL4*, TIMM8A*; MCART6,
SLC25A5, SLC25A43
Spastic paraplegia, SPG9 601162 paralysis-paresis, cataract, vomiting,
foot deformities
D10S564-D10S603 9.4 166 COX15*, ALDH18A1*; NDUFB8
#,
GOT1
#; C10orf65, SLC25A28
For each mitochondrial disorder (col.1), we identified the mitochondrial candidate genes (col.7) among all gene loci (col.6) in the genomic linkage interval (col.4). The
mitochondrial genes are further sorted into: (*) known disease genes with genes (in bold) causing phenotypic features (col.3) similar to features linked to the disease
interval; and (
#) predicted disease genes with genes (in bold) that interact to known disease genes causing features similar to the disease interval features. For
completeness, the unlabeled mitochondrial genes are not known or predicted disease genes.
doi:10.1371/journal.pcbi.1000374.t003
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wi~log N=df i ðÞ
  PMID for gene A-feature Fi ðÞ =
max PMID for feature Fi in one gene ½  ðÞ
 
PMID for gene B-feature Fi ðÞ =
max PMID for feature Fi in one gene ½  ðÞ
where N is the total number of genes (174) and df_i is the
document frequency of feature Fi in all genes, which is related to
the Inverse Document Frequency (IDF). IDF reflects the
hypothesis that the value of a feature varies inversely with the
number of genes in which it occurs [16]. To adjust for different
PMID counts for a feature in different genes, we set a denominator
as the maximum number of PMID in one gene associated with this
feature. QPA integrated the association ratios (ri) in all features Fi
(i=1, 2, 3, …, I) for gene pair A–B through weights of wi_max
which was calculated as:
QPA~ w1 r1zw2 r2zw3 r3z...zwI rI ðÞ =
w1zw2zw3z...zwI ðÞ
We identified feature Fi specific association ratios for 514,978
gene pairs (self-pairs removed), and computed QPA for 27,938
gene pairs with numerical values between 0.00177 and 1 (Table
S4). An example of calculating QPA for specific disease genes is
given under Text S1. In a related analysis, we studied associations
of genes and features after removing eleven features that describe
biochemical measurements of protein complexes (e.g. AKDH-
deficiency, RCC1-deficiency). Removing these features resulted in
9,298 gene-feature pairs. We identified high correlations for QPA
using the 9,298 versus all 9,407 gene-feature pairs, respectively
(Kendall Cor=0.9899, Spearman Cor=0.9981, and Pearson
Cor=0.9978). While biochemical measurements support the
diagnosis of many mitochondrial diseases, these features may not
be essential for QPA predictions.
Correlation of QPA and gene functional interactions
We extracted 2,010 disease gene pairs (140 genes) from a recent
study that had integrated microarray co-expression, human and
orthologous protein-protein interactions, and Gene Ontology
(GO) similarities into Likelihood Ratios (LR) for gene functional
interactions [34]. LR ranged from 1.1 to 2,374,581 and we used a
linear transformation for LR to fall into a range between 0 and 1:
tLR~ log LR ðÞ {min log LR ðÞ ðÞ ð =
max log LR ðÞ {min log LR ðÞ ðÞ ð ð
Overlapping all disease gene pairs with predictions for both LR
and QPA revealed 1,928 pairs (Table S4). Two-sided tests of
uniform distribution of LR and QPA for these pairs revealed non-
uniform distribution with p values of 2.2e-16 (significance level:
0.05). Rank correlation of LR and QPA for the 1,928 gene pairs
showed positive association with significant confidence: Kendall
(Cor=0.077; p=4.67e-7), Spearman (Cor=0.115; p=3.72e-7),
and Pearson (Cor=0.145; p=1.59e-10). Bivariate analysis and
Lowess plots further confirmed this finding (Figure S1). In
addition, we applied Euclidian distance and hierarchical average
linkage clustering (http://www.r-project.org) and identified six
gene clusters with higher to lower association of LR and QPA
(Figure S2 and Table S4).
Functional interactions of nuclear-encoded
mitochondrial genes
Out of the 174 DG, we identified functional interactions for 162
DG to 4,577 CG from a recent study [34]. As for the 162 DG, we
also recorded all genome-wide binary interactions for the 4,577 CG
with a total of 1,949,132 interactions. All gene interactions are non-
redundant and non-self-interacting. The interactions for the 4,577
CG included interactions to additional 5,358 genes that we labeled
CG interactors (CGin). We assigned the following four attributes to
thetotal10,097 genesthat includedDG,CG and CGin (TableS6):
i. 1,283 disease genes identified through OMIM [26]; ii. 1,032
human orthologs to mouse essential genes [33]; iii. 977 human
orthologs to yeast essential genes [37]; and iv. 863 nuclear-encoded
mitochondrial genes through integrative analysis of two studies
[5,36]. We then computed for each DG (162) and CG (4,577) the
total number of interactions (i[all-genes]), as well as all interactions
to genes with the assigned attributes (i–iv). Table S5 lists all
genome-wide interactions for the 4,739 genes (col. C) and
interactions to genes with the four attributes (col. D–G).
Functional interactions of non-mitochondrial genes
The analysis of interactions of the non-mitochondrial CG (3551)
and DG (493) showed the following results: i. the total number of
interactions (i[all-genes]), which is recorded to all genes in the
human genome, was higher for CG than for DG (p=3.67e-3); ii.
the relative number of DG interactions (i[disease-genes]/i[all-
genes]), which was recorded to all known human DG, was higher
for DG than for CG (p=1.07e-21); and iii. the relative number of
interactions to human orthologs of mouse (i[mouse-essential]/i[all-
genes]) and yeast (i[yeast-essential]/i[all-genes]) essential genes
[33,37] was higher for the DG than the CG (mouse p=3.77e-4;
yeast p=7.62e-7).
Gene fraction analysis
We studied the number of interactions (degree) of genes in the
different gene groups and the probability distribution of these
interactions (degree distribution) over the whole network. For each
gene group, we computed the degree distributions P(k) as the
fraction of the number of genes that interact with k other genes,
where the sum of fractions of a specific gene group is 1. Similar to
the study by Goh et al. [33], we used log2k as the dependent
variable in Figure 3. We calculated P(k) for interactions of each
gene group to all human genes (3A), all human disease genes (3B)
and all mitochondrial genes (3C) using data in Table S5. We then
performed a fraction analysis by applying the linear regression
model to the degree distributions of each gene group and attribute
using the R statistical package (http://www.r-project.org) and
calculated the values for the regression line slopes, their p-values
and correlation coefficients (Table S7). We found that the
measured trends described by the linear regression model are
statistically significant for all gene groups with very small p-values
(,10
28), which we obtained by testing the null hypothesis that the
slope is zero. The negative regression slopes identified for all gene
groups suggested a relatively higher portion of less-connected
genes and a lower tendency to form a hub structure. We then
ordered the gene groups using their slope values. The order was
based on the hypothesis that as larger the absolute value of the
negative regression slope, the higher the probability that lower-
connected genes outnumber the higher-connected genes. This
comparison showed that in the interactions to all genes (3A), DG
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mito (20.00072), and in the interactions to all disease genes (3B),
DG mito showed relatively more interactions (20.00612) than CG
mito (20.00776). Similar relationships were found in the
comparison of the mitochondrial gene groups based on their
correlation coefficients (Table S7). We concluded from these
results that while mitochondrial disease genes displayed an overall
smaller connectivity, they showed a tendency to interact with each
other suggesting the formation of disease gene hubs in the
periphery of the mitochondrial gene networks.
Candidate genes for mitochondrial disorders
We applied the two supervised methods of discriminant analysis
[43] and Bayesian network analysis [44,45] to predict new
mitochondrial DG. From Table S5, we selected 695 mitochon-
drial genes and their attributes of functional interactions and
labeled the 162 DG as DG, the 495 CG as CG, and the 38 likely
mitochondrial DG as CG to serve as controls. The linear
discriminant covariance analysis was performed using the JMP
statistical software with predictions results listed in Table S8 (col.
D–I). For the Bayesian network analysis (col. K–P), we first
selected 100 typical DG out of the 162 DG, and 100 typical CG
out of the 495 CG (col. K). The 200 genes were imported as
training sets into a machine-learning algorithm and the Bayesian
network package of this program was used to train the model by
the method of cross validation [44]. We then imported the test set
of all 695 mitochondrial genes in order to predict mitochondrial
DG. The overlap of the two applied methods (col. Q) predicted
168 high-probability disease candidate genes out of the 495 non-
disease CG.
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